Prevalence of anemia and renal insufficiency in non-hospitalized patients with heart failure;Prevalencia de anemia e insuficiencia renal en portadores de insuficiencia cardiaca no hospitalizados

Arquivos Brasileiros de Cardiologia

Volumn 93, Issue 3, 2009, Pages

  Dos Reis, Francisco José Farias Borges ^a   Fernandes, André Maurício Souza ^a   Bitencourt, Almir Galvão Vieira ^a   Neves, Flávia Branco Cerqueira Serra ^a   Kuwano, André Yoichi ^a   França, Victor Hugo Pinheiro ^a   De Macedo, Cristiano Ricardo Bastos ^a   Da Cruz, Cristiano Gonçalves ^a   Sahade, Viviane ^a   Aras Jr , Roque ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Anemia; Heart failure; Renal insufficiency

Indexed keywords

HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; ANEMIA; ARTICLE; CARDIAC PATIENT; CLINICAL EVALUATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; SYSTOLE; UNIVERSITY HOSPITAL; BRAZIL; CROSS-SECTIONAL STUDY; MIDDLE AGED; REFERENCE VALUE; STATISTICS;

ANEMIA; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; REFERENCE VALUES; RENAL INSUFFICIENCY;

EID: 70350749599     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009000900011     Document Type: Article

References (26)

1. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26: 1115-1140
2. Sales ALF, Villacorta H, Reis L, Mesquita ET. Anemia as a prognostic factor in a population hospitalized due to decompensated heart failure. Arq Bras Cardiol. 2005; 84: 237-240
3. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113: 671-678
4. Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A. The cardio-renal syndrome: does it exist? Nephrol Dial Transplant. 2003; 18 (Suppl.8): viii7-viii12.
5. Gil P, Justo S, Caramelo C. Cardio-renal failure: an emerging clinical entity. Nephrol Dial Transplant. 2005; 20: 1780-1783
6. Silverberg D. Outcomes of anaemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant. 2003; 18 (Suppl 2): ii7-ii12.
7. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (2 Suppl 1): S1-266.
8. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J. 2005; 149: 391-401.
9. Tang Y, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006; 113: 2454-2461
10. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000; 35: 1737-1744
11. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiffner D, Hess OM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol. 2002; 86: 115-121
12. Anand I, McMurray JJV, Whitmore J, Warren M, Pham A, McCamish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004; 110: 149-154
13. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006; 113: 986-994
14. Latado AL, Passos LC, Darze ES, Lopes AA. Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol. 2006; 98: 1631-1634
15. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004; 44: 959-966
16. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A. Erythropoietin should be part of congestive heart failure management. Kidney Int. 2003; 87 (Suppl): S40-7.
17. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J. 2005; 26: 11-17
18. de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol. 2006; 98: 391-398
19. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J. 2005; 26: 2232-2237
20. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003; 107: 226-229
21. Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, et al. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J. 2007; 28: 166-171
22. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001; 37: 1775-1780
23. Mancini DM, Katz SD, Lamanca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patientswith moderate to severe chronic heart failure. Circulation. 2003; 107: 294-299
24. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol. 2006; 48 (6): 1225-1227 (Pubitemid 44345150)
25. Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, et al. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant. 2003; 18 (1): 141-146 (Pubitemid 36104490)
26. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006; 38: 295-310. (Pubitemid 44138158)